Latest Headlines

31. QIAGEN Launches QIAsymphony Connect For Automated Clinical Nucleic Acid Extraction 8/27/2026

    QIAGEN N.V. today announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid extraction.

32. Roche Receives FDA Approval For Companion Diagnostic Tests To Identify Patients With HER2-Positive Metastatic Gastroesophageal Adenocarcinoma Eligible For ZIIHERA 8/27/2026

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA approval for expanded use of its PATHWAY® HER2 (4B5) and VENTANA® HER2 Dual ISH DNA Probe Cocktail tests.

33. New Approach Cuts Sepsis Diagnosis From Days To Hours, Researchers Report 8/26/2026

    Sepsis, a life-threatening condition that stems from the body trying to fight off an infection, plagues over 1.5 million patients a year in the U.S. alone, with one in three deaths recorded in the hospital attributed in part to sepsis.

34. Liebherr Strengthens Scientific Freezer Portfolio 8/25/2026

    Liebherr Appliances USA continues to strengthen its Scientific Laboratory portfolio with the introduction of two new freezer solutions designed to meet the demanding requirements of research, healthcare, pharmaceutical, and industrial laboratories.

35. Patented Device Reinvents Solid Phase Extraction 8/25/2026

    Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition. Small enough to fit in your lab coat pocket, yet so powerful it will accomplish complete SPE procedures within minutes.

36. Ataraxis AI's Laboratory Receives CAP Accreditation And California Clinical Laboratory License 8/25/2026

    Ataraxis AI, a frontier clinical artificial intelligence (AI) company developing AI-powered tools for oncology, today announced that its laboratory has received accreditation from the College of American Pathologists (CAP) and a clinical laboratory license from the State of California, expanding access to the Ataraxis Breast platform for clinicians and patients across the state.

37. Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers For Isotope Ratio Analysis, Enabling More Labs To Decode The Story Behind A Sample 8/25/2026

    Thermo Fisher Scientific, the world leader in serving science, today introduced the Thermo Scientific Orbitrap Isora Mass Spectrometer and Orbitrap Isora Pro Mass Spectrometer, the company’s first Orbitrap instruments with a dedicated isotope ratio analysis mode.

38. Labcorp To Offer First FDA-Cleared Blood Test To Detect Alzheimer's Disease Pathology In Both Primary And Specialty Care Settings 8/24/2026

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys® pTau-217 test following clearance by the U.S. Food and Drug Administration (FDA).

39. Quest Diagnostics To Offer FDA-Cleared Roche pTau217 Blood Test To Assess Alzheimer's Disease Pathology 8/24/2026

    Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced two new developments for its Quest AD-Detect® portfolio of blood-based biomarker tests for Alzheimer's disease, with the goal of broadening access to quality blood tests for evaluating symptomatic patients for Alzheimer's disease.

40. Purdue Innovation Enhances Multiomics Workflow, Eliminates Sample Preparation 8/24/2026

    A patent-pending method developed and tested for multiple applications at Purdue University eliminates sample preparation, a bottleneck that currently dominates a laboratory scientist’s time and budget, and is amenable with spatial analysis using liquid chromatography-tandem mass spectrometry (LC-MS/MS).